Quasi-drug law to be revised

A National Assembly committee Tuesday endorsed a revision of the Pharmaceutical Affairs Law requiring quasi-drug suppliers to make more detailed description of the ‘precaution in use’ into a monograph.

The bill passed by the Health and Welfare Committee is expected to reduce the possible side effects of quasi-drugs as it calls for the Korea Food and Drug administration to make public the adv...